About this Research Topic
Continuous analyses of epidemiology, microbiology, new therapeutic and prophylactic strategies are essential contributions to prevent colonization, to reduce spreading and to improve management of infections by MDROs in these patients’ categories. This Research Topic focuses on the emerging Gram negative MDROs, their resistance mechanisms, their epidemiology and new therapeutics in fragile hosts.
This Research Topic covers, but is not limited to, the following subtopics:
1. Epidemiology of different molecular mechanism of CRE and DTR-NFGN (Stenotrophomonas maltophilia, Acinetobacter baumannii and Pseudomonas aeruginosa) in solid organ transplant recipients, hematologic patients, elderly, people living with HIV (PLWH).
2. New antibiotic strategy to manage clinical infections by CRE and DTR-NFGN in solid organ transplant recipients, hematologic patients, elderly, other immunocompromised hosts based on different molecular resistance mechanisms.
3. Prevalence of different genotypes of Gram-negative MDROs and their possible interaction with saprophytic microbiota in colonized solid organ transplant recipients, hematologic patients, elderly, other immunocompromised hosts.
4. Prevalence of different genotypes of Gram negative MDROs and outcomes of related infections in solid organ transplant recipients, hematologic patients, elderly, other immunocompromised hosts.
We welcome the following article types:
1. For the Antimicrobials, Resistance and Chemotherapy section: Methods, Mini Review, Original Research, Perspective, Review, Systematic Review.
2. For the Clinical infectious Diseases section: Methods, Mini Review, Original Research, Perspective, Review.
3. For the Hematologic Malignancies section: Brief Research Report, Clinical Trial, Mini Review, Original Research, Review, Systematic Review.
Keywords: Multiresistance, Gram negative, Immunocompromised host, Elderly, Transplanted host, Hematologic host, Therapy, Epidemiology, Resistance mechanism
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.